1 / 5

Chronic Liver Disease Market Size, Share Analysis 2023

The latest report by Precision Business Insights, titled u201cChronic Liver Disease Marketu201d covers complete information on market size, share, growth, trends, segment analysis, key players, drivers, and restraints.

32216
Télécharger la présentation

Chronic Liver Disease Market Size, Share Analysis 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Chronic Liver Disease Market (2023-29) 1

  2. Market Overview: The global chronic liver disease market size was valued at USD 22,143 million in 2022 and is poised to grow at a significant CAGR of 7% during the forecast period 2023-29. The chronic liver disease market research report also provides opportunities for business owners to exploit through the use of relevant approaches. The study’s prospects assist stakeholders and report purchasers in properly planning their investments and augmenting their profits. The report provides a quantitative analysis of the market segments, trends, estimations, and dynamics of the chronic liver disease market analysis from 2023 to 2029 to identify the prevailing market opportunities. In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years. View Detailed Report Description 2

  3. Market Segments: The chronic liver disease market has been fragmented based on: 1) By Treatment: Antiviral Drugs, Immunosuppressant, Vaccines, Immunoglobulin, Corticosteroids, Targeted Therapy, and Chemotherapy 2) By Disease Type: Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, Others 3) By Diagnosis Technique: Laboratory Tests, Imaging, Endoscopy, Biopsy, and Others 4) By End Users: Hospitals, Ambulatory Surgery Centers, Specialty Clinics, Others Request Sample Report 3

  4. Key Players: Some of the major key players in the chronic liver disease market are: Abbott Laboratories Astellas Pharma Inc. Bristol-Myers Squibb Company Gilead Sciences GlaxoSmithKline PLC Hoffmann-La Roche Ltd. Request Sample Report 4

  5. Europe Office: Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Asia-Pacific Office: Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad – 500072 Email: sales@precisionbusinessinsights.com Toll-Free: +1-866-598-1553 5

More Related